BOSTON: Moderna on Wednesday said its flu vaccine had generated a stronger immune response against all four A and B strains of the influenza virus compared to traditional flu shots in a late-stage trial.
The company had previously said that there was not enough available data to determine whether the flu vaccine would succeed after it failed to meet the “early-success” criteria in the study. Moderna said it could launch up to 15 products over the next five years, as it moves focus away from its Covid vaccine.The company is in talks with its partners that fill vials and syringes with its messenger RNA-based Covid vaccines globally to downsize production, Stephen Hoge, president of the Massachusetts-based company, said in an interview.
“Over the past couple of years, we’ve been in pandemic mode producing a billion doses a year,” Hoge said. “We’ve been waiting for the moment when the pandemic was officially behind us that we would need to restructure that manufacturing footprint.”
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: staronline - 🏆 4. / 75 Read more »
Source: fmtoday - 🏆 5. / 72 Read more »
Source: fmtoday - 🏆 5. / 72 Read more »
Source: fmtoday - 🏆 5. / 72 Read more »
Source: fmtoday - 🏆 5. / 72 Read more »
Source: Kotaku - 🏆 2. / 86 Read more »